Abstract
Immunophenotypic analysis identified a BM CD57+CXCR3+ subset of CD8+ T cells associated with response to AZA in patients with MDS and AML. Single-cell RNA sequencing analysis revealed that IFN signaling is linked to the response to treatment, whereas TGF-β signaling is associated with treatment failure, providing insights into new therapeutic approaches.
©2024 The Authors; Published by the American Association for Cancer Research.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Antimetabolites, Antineoplastic / pharmacology
-
Antimetabolites, Antineoplastic / therapeutic use
-
Azacitidine* / pharmacology
-
Azacitidine* / therapeutic use
-
Bone Marrow / drug effects
-
Bone Marrow / pathology
-
CD8-Positive T-Lymphocytes* / drug effects
-
CD8-Positive T-Lymphocytes* / immunology
-
Disease Progression*
-
Female
-
Humans
-
Leukemia, Myeloid, Acute / drug therapy
-
Leukemia, Myeloid, Acute / immunology
-
Leukemia, Myeloid, Acute / pathology
-
Male
-
Middle Aged
-
Myelodysplastic Syndromes* / drug therapy
-
Myelodysplastic Syndromes* / pathology
-
Signal Transduction / drug effects
-
Single-Cell Analysis*
Substances
-
Azacitidine
-
Antimetabolites, Antineoplastic